A case report: rapid progression of coronary atherosclerosis in a patient taking Targretin (Bexarotene)

Research output: Contribution to journalArticlepeer-review

Abstract

Anti-neoplastic drugs have made major advancements in oncology, however they are not without cardiovascular consequences. We present a patient with cutaneous T-cell lymphoma receiving Targretin therapy who presented with accelerated atherosclerosis. His triglyceride level (TG) was greater than 1000 mg/dL, which rapidly improved with discontinuation of Targretin.

Original languageEnglish (US)
Article number31
JournalCardio-Oncology
Volume6
Issue number1
DOIs
StatePublished - Dec 2020

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'A case report: rapid progression of coronary atherosclerosis in a patient taking Targretin (Bexarotene)'. Together they form a unique fingerprint.

Cite this